Artificial Intelligence | Machine Learning | Natural Language Processing Ablacon | AI-guided Atrial Fibrillation Therapies.

Consumer, Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support Greater Denver Area, Western US, CO, United States

Artificial Intelligence | Machine Learning | Natural Language Processing

Ablacon | AI-guided Atrial Fibrillation Therapies.

Heart, Therapeutics, Healthcare, Medical Records, Analytics, Patient Support

Greater Denver Area, Western US, CO, United States

Atrial Fibrillation (AF) is the most frequent arrhythmic disorder of the heart. At Ablacon, we leverage our expertise in electrophysiology, computer vision and deep learning to build a real-time high-precision AI-based diagnosis system.

We are an international team based in Lausanne (CH), Denver, CO (US) and Munich (DE) with a partner clinic in Hamburg (DE).

B2G, B2B

26 to 50

Series B

$33.5M

Development

2015

Managed Health Care
Healthcare
Health Care Facilities & Hospitals

N/A

Healthcare

Analytics
IT and Security

Yes

Active

Machine Learning
Natural Language Processing

Electrographic Flow Mapping

Image

Video

Text

Time Series

Software

Duke Rohlen
CEO

Josef Koblish
Chief Strategy Officer

Peter Ruppersberg
Chief Scientific Officer & President

Melissa Kong
Associate Medical Director

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Ablacon

Ablacon - Manage Profile